tetano
Editor, Senior Moderator
J Transl Med
. 2023 May 31;21(1):358.
doi: 10.1186/s12967-023-04224-1. Single-cell analysis of adult human heart across healthy and cardiovascular disease patients reveals the cellular landscape underlying SARS-CoV-2 invasion of myocardial tissue through ACE2
Cong Chen[SUP] 1 [/SUP], Jie Wang[SUP] 2 [/SUP], Yong-Mei Liu[SUP] 1 [/SUP], Jun Hu[SUP] 1 [/SUP]
Affiliations
Background: The distribution of ACE2 and accessory proteases (ANAD17 and CTSL) in cardiovascular tissue and the host cell receptor binding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are crucial to understanding the virus's cell invasion, which may play a significant role in determining the viral tropism and its clinical manifestations.
Methods: We conducted a comprehensive analysis of the cell type-specific expression of ACE2, ADAM17, and CTSL in myocardial tissue from 10 patients using RNA sequencing. Our study included a meta-analysis of 2 heart single-cell RNA-sequencing studies with a total of 90,024 cells from 250 heart samples of 10 individuals. We used co-expression analysis to locate specific cell types that SARS-CoV-2 may invade.
Results: Our results revealed cell-type specific associations between male gender and the expression levels of ACE2, ADAM17, and CTSL, including pericytes and fibroblasts. AGT, CALM3, PCSK5, NRP1, and LMAN were identified as potential accessory proteases that might facilitate viral invasion. Enrichment analysis highlighted the extracellular matrix interaction pathway, adherent plaque pathway, vascular smooth muscle contraction inflammatory response, and oxidative stress as potential immune pathways involved in viral infection, providing potential molecular targets for therapeutic intervention. We also found specific high expression of IFITM3 and AGT in pericytes and differences in the IFN-II signaling pathway and PAR signaling pathway in fibroblasts from different cardiovascular comorbidities.
Conclusions: Our data indicated possible high-risk groups for COVID-19 and provided emerging avenues for future investigations of its pathogenesis.
Trial registration: (Not applicable).
Keywords: ACE2; ADAM17; COVID-19; CTSL; Heart; SARS-CoV-2; scRNA-seq.
. 2023 May 31;21(1):358.
doi: 10.1186/s12967-023-04224-1. Single-cell analysis of adult human heart across healthy and cardiovascular disease patients reveals the cellular landscape underlying SARS-CoV-2 invasion of myocardial tissue through ACE2
Cong Chen[SUP] 1 [/SUP], Jie Wang[SUP] 2 [/SUP], Yong-Mei Liu[SUP] 1 [/SUP], Jun Hu[SUP] 1 [/SUP]
Affiliations
- PMID: 37259108
- DOI: 10.1186/s12967-023-04224-1
Background: The distribution of ACE2 and accessory proteases (ANAD17 and CTSL) in cardiovascular tissue and the host cell receptor binding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are crucial to understanding the virus's cell invasion, which may play a significant role in determining the viral tropism and its clinical manifestations.
Methods: We conducted a comprehensive analysis of the cell type-specific expression of ACE2, ADAM17, and CTSL in myocardial tissue from 10 patients using RNA sequencing. Our study included a meta-analysis of 2 heart single-cell RNA-sequencing studies with a total of 90,024 cells from 250 heart samples of 10 individuals. We used co-expression analysis to locate specific cell types that SARS-CoV-2 may invade.
Results: Our results revealed cell-type specific associations between male gender and the expression levels of ACE2, ADAM17, and CTSL, including pericytes and fibroblasts. AGT, CALM3, PCSK5, NRP1, and LMAN were identified as potential accessory proteases that might facilitate viral invasion. Enrichment analysis highlighted the extracellular matrix interaction pathway, adherent plaque pathway, vascular smooth muscle contraction inflammatory response, and oxidative stress as potential immune pathways involved in viral infection, providing potential molecular targets for therapeutic intervention. We also found specific high expression of IFITM3 and AGT in pericytes and differences in the IFN-II signaling pathway and PAR signaling pathway in fibroblasts from different cardiovascular comorbidities.
Conclusions: Our data indicated possible high-risk groups for COVID-19 and provided emerging avenues for future investigations of its pathogenesis.
Trial registration: (Not applicable).
Keywords: ACE2; ADAM17; COVID-19; CTSL; Heart; SARS-CoV-2; scRNA-seq.